These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21506544)

  • 1. Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states.
    Miller Y; Ma B; Nussinov R
    Biochemistry; 2011 Jun; 50(23):5172-81. PubMed ID: 21506544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Aβ and mutated Tau lead to polymorphism and induce aggregation of Aβ-mutated tau oligomeric complexes.
    Raz Y; Miller Y
    PLoS One; 2013; 8(8):e73303. PubMed ID: 23951348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between amyloid-β and Tau fragments promote aberrant aggregates: implications for amyloid toxicity.
    Do TD; Economou NJ; Chamas A; Buratto SK; Shea JE; Bowers MT
    J Phys Chem B; 2014 Sep; 118(38):11220-30. PubMed ID: 25153942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Binding and Conformational Dynamics of Tau Microtubule-Binding Repeats with a Preformed Amyloid-β Fibril Seed.
    Song Z; Gatch AJ; Sun Y; Ding F
    ACS Chem Neurosci; 2023 Apr; 14(7):1321-1330. PubMed ID: 36975100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer's Pathogenesis.
    Penke B; Szűcs M; Bogár F
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32260279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau aggregation followed by atomic force microscopy and surface plasmon resonance, and single molecule tau-tau interaction probed by atomic force spectroscopy.
    Barrantes A; Sotres J; Hernando-Pérez M; Benítez MJ; de Pablo PJ; Baró AM; Avila J; Jiménez JS
    J Alzheimers Dis; 2009; 18(1):141-51. PubMed ID: 19625749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of each repeat structure of the microtubule-binding domain of the tau protein in in vitro aggregation.
    Tomoo K; Yao TM; Minoura K; Hiraoka S; Sumida M; Taniguchi T; Ishida T
    J Biochem; 2005 Oct; 138(4):413-23. PubMed ID: 16272135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage.
    Wallin C; Hiruma Y; Wärmländer SKTS; Huvent I; Jarvet J; Abrahams JP; Gräslund A; Lippens G; Luo J
    J Am Chem Soc; 2018 Jul; 140(26):8138-8146. PubMed ID: 29708745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies.
    Zheng Q; Kebede MT; Kemeh MM; Islam S; Lee B; Bleck SD; Wurfl LA; Lazo ND
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31234523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.
    Shin WS; Di J; Cao Q; Li B; Seidler PM; Murray KA; Bitan G; Jiang L
    Alzheimers Res Ther; 2019 Oct; 11(1):86. PubMed ID: 31627745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.
    Guo JP; Arai T; Miklossy J; McGeer PL
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1953-8. PubMed ID: 16446437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spreading of Pathology in Alzheimer's Disease.
    Lv ZY; Tan CC; Yu JT; Tan L
    Neurotox Res; 2017 Nov; 32(4):707-722. PubMed ID: 28623460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.